An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Methyl aminolevulinate (MAL) is a drug used as a sensitizer in photodynamic therapy. It is a prodrug that is metabolized to protoporphyrin IX. It is marketed as Metvix. Metvix cream is applied topically and some time later the skin is illuminated with a proprietary red light (630 nm) source (medical lamp 'Aktilite') to activate the photosensitiser. Metvix is developed by Photocure and Galderma has bought all rights to Metvix.

Property Value
dbo:abstract
  • Methyl-5-amino-4-oxopentanoat (MAOP), Internationaler Freiname Methyl(5-amino-4-oxopentanoat)-hydrochlorid, ist ein Arzneistoff zur photodynamischen Therapie (PDT) von oberflächlichen und knotigen Basaliomen und aktinischen Keratosen. (de)
  • Methyl aminolevulinate (MAL) is a drug used as a sensitizer in photodynamic therapy. It is a prodrug that is metabolized to protoporphyrin IX. It is marketed as Metvix. Metvix cream is applied topically and some time later the skin is illuminated with a proprietary red light (630 nm) source (medical lamp 'Aktilite') to activate the photosensitiser. Metvix is developed by Photocure and Galderma has bought all rights to Metvix. (en)
dbo:casNumber
  • 33320-16-0
dbo:chEMBL
  • 1096562
dbo:drugbank
  • DB00992
dbo:fdaUniiCode
  • 585NM85KYM
dbo:pubchem
  • 157922
dbo:thumbnail
dbo:wikiPageID
  • 6608023 (xsd:integer)
dbo:wikiPageLength
  • 4364 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1120099605 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • L01 (en)
dbp:atcSuffix
  • XD03 (en)
dbp:c
  • 6 (xsd:integer)
dbp:casNumber
  • 33320 (xsd:integer)
dbp:chembl
  • 1096562 (xsd:integer)
dbp:chemspiderid
  • 13180320 (xsd:integer)
dbp:drugbank
  • DB00992 (en)
dbp:h
  • 11 (xsd:integer)
dbp:iupacName
  • Methyl 5-amino-4-oxopentanoate (en)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 3 (xsd:integer)
dbp:pubchem
  • 157922 (xsd:integer)
dbp:smiles
  • O=CC (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • FLQHIIVXMKXKFT-UHFFFAOYSA-N (en)
dbp:unii
  • 585 (xsd:integer)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 470457959 (xsd:integer)
dbp:watchedfields
  • changed (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Methyl-5-amino-4-oxopentanoat (MAOP), Internationaler Freiname Methyl(5-amino-4-oxopentanoat)-hydrochlorid, ist ein Arzneistoff zur photodynamischen Therapie (PDT) von oberflächlichen und knotigen Basaliomen und aktinischen Keratosen. (de)
  • Methyl aminolevulinate (MAL) is a drug used as a sensitizer in photodynamic therapy. It is a prodrug that is metabolized to protoporphyrin IX. It is marketed as Metvix. Metvix cream is applied topically and some time later the skin is illuminated with a proprietary red light (630 nm) source (medical lamp 'Aktilite') to activate the photosensitiser. Metvix is developed by Photocure and Galderma has bought all rights to Metvix. (en)
rdfs:label
  • Methyl-5-amino-4-oxopentanoat (de)
  • Methyl aminolevulinate (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License